All In MedTech

Device Trial Radar · NCT04599907

Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating

An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating

Last checked: Nov 19, 2026Latest source record: Sep 7, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

120

Actual

Start

Oct 13, 2020

Primary completion

Jul 6, 2021

Study completion Dec 20, 2021

Sponsor

Lead sponsor
Candesant Biomedical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Oct 23, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Sahara Study is a study to evaluate the safety and effectiveness of the N-SWEAT Patch for use in subjects with excessive axillary sweating, or primary focal axillary hyperhidrosis.

Conditions

  • Primary Axillary Hyperhidrosis

Interventions

  • Roll-In Cohort: Single Application of N-SWEAT PatchDevice

    Single Application of N-SWEAT Patch in both axillae for 10 subjects

  • Randomized Cohort: Single Application of N-SWEAT PatchDevice

    Single Application of N-SWEAT Patch in both axillae for subjects randomized to the treatment group

  • Randomized Cohort: Single Application of Sham PatchDevice

    Single Application of Sham Patch in both axillae for subjects randomized to the control group

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of the N-SWEAT PatchTime frame: 4 weeks
  2. Effectiveness of the N-SWEAT Patch to Change Subjects From an HDSS 3 or 4 at Baseline to HDSS 1 or 2 at 4 WeeksTime frame: 4 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • CA Dermatology & Clinical Research Inst

    Encinitas, California

  • Center for Dermatology Clinical Research

    Fremont, California

  • AE Derm

    Rockville, Maryland

6 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.